Five Elected to Arcadia University’s Board of Trustees
Ronald Eicholtz, Sara Lomax-Reese, James Moran, Daniel Rivera ’17, and John Rollins have been elected to the Arcadia University Board of Trustees. The five individuals bring a wealth of experience in a diverse range of professions, including in the biomedical, finance, health care, and media industries.
“Over the past sixteen months, we have made it a priority to solidify our Board with members who could serve alongside current Trustees in providing leadership, stability, and vision to Arcadia University,” said Dr. Ajay Nair, president of Arcadia University. “These five individuals bring with them a diverse range of experience and expertise that will help Arcadia as we move forward with our next strategic plan. We are grateful for their commitment to our University, our students, and our community members.”
Ronald Eicholtz
For two decades, Eicholtz held several finance positions with Johnson Controls and its predecessor, Tyco International. Until 2017, Eicholtz was vice president of finance at Johnson Controls, a multinational HVAC company with annual sales of $30 billion. Prior to that, he was vice president of finance for Tyco International and Tyco Security Products. Since 2017, Eicholtz has owned C&R Home Buyers, LLC, a real estate investment company.
Eicholtz, who earned a Bachelor of Science in economics at Florida State University, serves on the Stewardship Committee at St. Mary’s Medical Rehabilitation Hospital. His tenure as a trustee at Arcadia began on June 1.
Sara Lomax-Reese
Lomax-Reese is president and CEO of WURD Radio 900AM / 96.1FM, Philadelphia’s only African American owned talk radio station. In 2018, Lomax-Reese spearheaded the launch of a new environmental justice journalism platform, ecoWURD, as part of the Civil digital platform. Prior to her work with WURD, she co-founded HealthQuest: Total Wellness for Body, Mind, & Spirit, a trailblazing African American consumer health magazine that grew from a quarterly publication to a bi-monthly with a national circulation of more than 500,000.
Lomax-Reese has earned several awards, including the Beacon of Light Award from the Congressional Black Caucus, the Women of Substance Award from the National Medical Association, and the 2017 Trailblazer Award from the Philadelphia Association of Black Journalists. She serves on a variety of boards, including the Lenfest Institute for Journalism and Drexel University’s College of Medicine Advisory Council. Lomax-Reese is a graduate of the University of Pennsylvania and earned a Master of Science in Journalism from Columbia University. She has written for the Miami Herald, The Philadelphia Inquirer, the Atlanta Journal-Constitution, Essence Magazine, American Visions Magazine, and Modern Maturity, and in 2018, she was named one of the “100 Most Influential Philadelphians” by Philadelphia Magazine. Her tenure as a trustee at Arcadia began Aug. 1.
James Moran
Moran is president and CEO of Biocoat, Inc., a global medical device coating company based in Horsham, Pa. Biocoat was founded as Beacon Research in 1984 by Dr. Ellington Beavers ’93H at Arcadia University and was housed in the University’s science building, Boyer Hall, until moving to its Horsham base in 2006.
Prior to joining Biocoat, Moran was vice president of marketing, North America, for Bracco International Group, a company specializing in diagnostic imaging drugs, Injector and Software Informatic marketing with $1.45 billion in annual sales. Moran also served as vice president of sales and business development at Acclarent, a subsidiary of Johnson & Johnson that has more than $76 billion in annual sales, and as a business development consultant for Publicis Touchpoint Solutions, a firm based in Yardley, Pa. that designs and implements customized health care sales, service, and communications teams. Moran had additional international experience as president of ConvaTec Japan in Tokyo, and as vice president and general manager of Ostomy Care for ConvaTec, Inc., a market leader in advanced wound and ostomy care located in Reading, Berkshire, England. In addition, Moran is co-founder and CEO of Jazz Medical, a company whose mission is to bring advanced wound care products into the veterinary market.
Moran earned a Bachelor of Science in Marketing from St. Joseph’s University and a Master of Business Administration from the University of Phoenix. He is a member of the Board of Visitors at St. Joseph’s University and his tenure as a trustee at Arcadia began on July 1.
Daniel Rivera
A 2017 graduate of Arcadia University, Rivera will serve a two-year term as a recent graduate trustee. Rivera is a community workforce connector and manages a new PA Careerlink HUB at the Community College of Philadelphia’s Northeast Regional Center.
Rivera, who also is a member of the Young Alumni and Student Committee at Arcadia, earned a Bachelor of Arts in Political Science and Spanish. As a student, Rivera was a student representative for the Presidential Search Committee, a peer mentor for the Gateway to Success/Act101 Program, and president of the Student Government Organization.
John Rollins
From 2007 to 2016, Rollins served as executive vice president at Accolade, Inc., an on-demand health care concierge for employers, health plans, and health systems. Prior to his leadership at Accolade, Rollins was a managing partner for Accenture, a global management consulting and professional services firm that provides strategy, consulting, digital, technology, and operations services.
Rollins is chair of the Board of Directors for the Wilma Theater and former board chair for both the Green Tree Community Health Foundation and the Friends of the Wissahickon. He is a Board member for the Academy of Vocal Arts and previously served on the Board of the Opera Company of Philadelphia. A graduate of Carnegie Mellon University, Rollins earned a Master of Business Administration with an emphasis in corporate finance and investment management at the Wharton School of Business at the University of Pennsylvania. His tenure as a trustee at Arcadia began Aug. 1.